Thrilled to announce that we have closed a $50 million extension to our series B financing, with the total for the round now exceeding $150 million. Proceeds will be used to broaden our pipeline of AI-discovered clinical and pre-clinical oncology programs and further advance our AI/ML and automated experimentation platform. We want to thank Mubadala Capital and Exor Ventures for leading the round and all of the new and existing investors for their participation. Learn more in today’s press release: https://lnkd.in/eQk6jD96 #AI #ML #Drugdiscovery
Impressive!
Awesome Tony!
Did they give all that to you? If so, you pay for the golf from now on. 😀 ⛳